Objective: To evaluate the effect of cytotoxic chemotherapy on survival in patients with non-
small cell lung cancer. Design: Meta-analysis using updated data on individual patients from …

Background: In 1995 a meta-analysis of randomised trials investigating the value of adding
chemotherapy to primary treatment for non-small cell lung cancer (NSCLC) suggested a …

Objectives: The non-small cell lung cancer (NSCLC) meta-analysis suggested a survival
benefit for cisplatin-based chemotherapy when given in addition to surgery, radical …

The last decade has seen the introduction of several new chemotherapeutic agents that
have activity against non-small cell lung cancer (NSCLC) and produce single-agent …

A systematic review of chemotherapy trials in several tumour types was performed by The
Swedish Council of Technology Assessment in Health Care (SBU). The procedures for the …

Study objective To contribute to the current debate about the relative merits of meta-analysis
of the literature (MAL) and of individual patients data (MAP). Design Identification of …

Background Lung cancer is considered a terminal illness with a five-year survival rate of
about 16%. Informed decision-making related to the management of a disease requires …

PURPOSE To estimate the impact of chemotherapy on survival of patients with advanced
non-small-cell lung cancer (NSCLC). METHODS Randomized controlled trials (RCTs) …

The objectives for the treatment of advanced nonsmall cell lung cancer are palliative and
include improvement of survival, symptom control, quality of life and cost. The level of …

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy
for Stage IV Non–Small-Cell Lung Cancer | JCO Oncology Practice Skip to main content …